ログイン

3

3
40問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    Which of the following is used to detect allergen specific IgE? RIST IEP RAST CRP

    RAST

  • 2

    A child has severe hay fever. A total IgE measurement was performed by the Ouchterlony immunodiffusion method. No lines of precipitation appeared on the immunodiffusion plate. The most likely explanation is: a IgE antibodies are not produced in children who have hay fever b hay fever is mediated by the cellular system c IgE is in too low a concentration to be detected by this method d IgA is the antibody commonly produced in people with hay fever

    c IgE is in too low a concentration to be detected by this method

  • 3

    Which test is used to evaluate the cellular immune system in a patient? a_ skin test for commonly encountered antigens b determination of isohemagglutinin titer ¢ immunoelectrophoresis of serum d measurement of anti-HBsAg after immunization

    a_ skin test for commonly encountered antigens

  • 4

    T cells are incapable of: collaborating with B cells in antibody responses secretion of immunoglobulins secretion of cytokines producing positive skin tests

    secretion of immunoglobulins

  • 5

    T lymphocytes are incapable of functioning as: a cytotoxic cells b helper cells c phagocytic cells d regulatory cells

    c phagocytic cells

  • 6

    Nonspecific killing of tumor cells is carried out by: cytotoxic T cells helper T cells natural killer cells antibody and complement

    natural killer cells

  • 7

    Tumor markers found in the circulation are most frequently measured by: a immunoassays b thin-layer chromatography c high-pressure liquid chromatography d colorimetry

    a immunoassays

  • 8

    A patient with a B-cell deficiency will most likely exhibit: decreased phagocytosis increased bacterial infections decreased complement levels increased complement levels

    increased bacterial infections

  • 9

    patient with a T-cell deficiency wil! most likely exhibit: increased immune complex formation increased parasitic infections decreased IgE-mediated responses decreased complement levels

    increased parasitic infections

  • 10

    Which of the following is an important cellular mediator of immune complex tissue injury? a mast cell b neutrophil c basophil d eosinophil

    b neutrophil

  • 11

    hich of the following mediators is released during T-cell activation? immunoglobulins thymosin serotonin cytokines

    cytokines

  • 12

    The HLA antibodies used in histocompatibility typing have been obtained from which of the following? multiparous women nonidentical siblings sheep blood rabbit serum

    multiparous women

  • 13

    Which of the following terms describes a graft between genetically unidentical individuals belonging to the same species? autograft isograft allograft xenograft

    allograft

  • 14

    Incompatibility by which of the following procedures is an absolute contraindication to allotransplantation? a MLC (mixed lymphocyte culture) b HLA typing c Rh typing d ABO grouping

    d ABO grouping

  • 15

    Which is a recognized theory of the origin of autoimmunity? a enhanced regulatory T-cell function b diminished helper T-cell activity c production of antibodies that cross-react with tissue components d deficient B-cell activation

    c production of antibodies that cross-react with tissue components

  • 16

    C3b and Fc receptors are present on: B lymphocytes monocytes B lymphocytes and monocytes neither B lymphocytes and monocytes

    B lymphocytes and monocytes

  • 17

    T lymphocytes that possess the CD8 surface marker mediate which of the following T-cell functions? delayed type hypersensitivity regulatory cytotoxic helper

    helper

  • 18

    Delayed hypersensitivity may be induced by: contact sensitivity to inorganic chemicals transfusion reaction anaphylactic reaction bacterial septicemia

    contact sensitivity to inorganic chemicals

  • 19

    The most rapid immediate hypersensitivity reaction is associated with: transfusion anaphylaxis contact dermatitis serum sickness

    anaphylaxis

  • 20

    The normal controls for a quantitative B lymphocyte assay should have a value of what percentage of total lymphocytes counted? a 21% b 48% c 76% d 89%

    a 21%

  • 21

    An immunofluorescence test using reagent antibody directed against the CD3 surface marker would identify which of the following cell types in a sample of human peripheral blood? all mature T lymphocytes T helper lymphocytes only cytotoxic T lymphocytes only T regulatory cells only

    all mature T lymphocytes

  • 22

    Refer to the following results for peripheral blood samples: % T lymphocytes patient #1: 85% patient #2: 23% patient #3: 51% patient #4: 82% normal control: 44% The data above indicates: a patient #1 has an abnormally high T lymphocyte count b patient #2 has a normal T lymphocyte count ¢ patients #1 and #3 have normal T lymphocyte counts d_ the normal control is too low and another sample should be selected

    the normal control is too low and another sample should be selected

  • 23

    Refer to the following flow cytometric data. absolute WBC: 8,930 total lymphocytes: 30% B lymphocytes: 40% T lymphocytes: 58% Calculate the absolute count for B lymphocytes. a 1,072 b 2,679 c 3,572 d 6,251

    a 1,072

  • 24

    A concentrate of lymphocytes can be prepared from peripheral blood by: a density gradient centrifugation b ultracentrifugation c zone electrophoresis d_ freeze fractionation

    a density gradient centrifugation

  • 25

    In flow cytometry, labeled cells: scatter the light and absorb fluorescence absorb fluorescence and emit electronic impulses scatter the light and emit fluorescence absorb both fluorescence and light

    scatter the light and emit fluorescence

  • 26

    A marked decrease in the CD4 lymphocytes and decrease in the CD4/CD8 ratio: is diagnostic for bacterial septicemia may be seen in most hereditary immunodeficiency disorders is associated with a viral induced immunodeficiency is only seen in patients with advanced disseminated cancer

    is associated with a viral induced immunodeficiency

  • 27

    Refer to the following data from a peripheral blood sample: total WBC: 10.0 x 109/uL Differential: neutrophils: 68% lymphocytes: 25% (40% T cells) monocytes: A% eosinophils: 2% basophils: 1% The expected total number of T cells is: a 200 b 1,000 c 2,000 d 2,500

    b 1,000

  • 28

    A peripheral blood total leukocyte count is 10.0 x 103/yL. The differential reveals 55% neutrophils, 2% eosinophils, 40% lymphocytes and 3% monocytes. Assuming a lymphocyte recovery of 85%-95%, what is the expected number of T cells in a normal individual? a 750/pL b 2,500/pL © 4,000/pL d 8,000/pL

    b 2,500/pL

  • 29

    In laser flow cytometry, applying a voltage potential to sample droplets as they stream past the light beam and using charged deflector plates results in: an emission of red fluorescence from cells labeled with fluorescein isothiocyanate an emission of green fluorescence from cells labeled with rhodamine a 90° light scatter related to cell size the separation of cells into subpopulations based on their charge

    the separation of cells into subpopulations based on their charge

  • 30

    What is the immunologic method utilized in the flow cytometer? latex agglutination enzyme linked immunoassay immunofluorescence radioimmunoassay

    immunofluorescence

  • 31

    Given the following data: WBC: 5.0 x 10%pL lymphs: 15% CD4: 8% Calculate the absolute CD4: a 40 b 60 c 400 d 750

    b 60

  • 32

    Given this hematologic data: WBC: 5.0 x 103/uL lymphs: 15% cD4: 8% Which of the following is the correct interpretation? a CD4% and absolute CD4 normal b consistent with an intact immune system c consistent with a viral infection such as HIV d technical error

    c consistent with a viral infection such as HIV

  • 33

    Bone marrow transplant donors and their recipients must be matched for which antigen system(s)? ABO-Rh HLA CD4/CD8 P1^a1

    HLA

  • 34

    A 28-year-old man is seen by a physician because of several months of intermittent low back pain. The patient's symptoms are suggestive of ankylosing spondylitis. Which of the following laboratory studies would support this diagnosis? a a decreased synovial fluid CHsp level b low serum CH50 level c positive HLA-B27 antigen test d rheumatoid factor in the synovial fluid

    c positive HLA-B27 antigen test

  • 35

    Cells from a patient with hairy cell leukemia have immunologic and functional features of: a mast cells and B lymphocytes b B lymphocytes and T lymphocytes c granulocytes and monocytes d B lymphocytes and monocytes

    d B lymphocytes and monocytes

  • 36

    Which T-cell malignancy may retain “helper” activity with regard to immunoglobulin synthesis by B cells? Hodgkin lymphoma acute lymphocytic leukemia (ALL) Sézary syndrome chronic lymphocytic leukemia (CLL)

    Sézary syndrome

  • 37

    patient’s abnormal lymphocytes are positive for CD2 antigen, lack C3 receptors, and are negative for surface immunoglobulin. This can be classified as a disorder of: T cells B cells monocytes natural killer cells

    T cells

  • 38

    HLA typing of a family yields the following results: On the basis of these genotypes, predict the possibility of ankylosing spondylitis in this percentage Locus A Locus B father (8, 12) (17, 22) mother (7, 12) (13, 27) of their children. a 25% of their children b 50% of their children c 75% of their children d 100%

    b 50% of their children

  • 39

    HLA-B8 antigen has been associated with which of the following pairs of diseases? an op ankylosing spondylitis and myasthenia gravis celiac disease and ankylosing spondylitis myasthenia gravis and celiac disease Reiter disease and multiple sclerosis

    myasthenia gravis and celiac disease

  • 40

    Which of the following is an important marker for the presence of immature B cells in patients with acute lymphocytic leukemia (ALL)? ans oe terminal deoxynucleotidyl transferase (TdT) adenosine deaminase glucose-6-phosphate dehydrogenase purine nucleoside phosphorylase

    terminal deoxynucleotidyl transferase (TdT)

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    Which of the following is used to detect allergen specific IgE? RIST IEP RAST CRP

    RAST

  • 2

    A child has severe hay fever. A total IgE measurement was performed by the Ouchterlony immunodiffusion method. No lines of precipitation appeared on the immunodiffusion plate. The most likely explanation is: a IgE antibodies are not produced in children who have hay fever b hay fever is mediated by the cellular system c IgE is in too low a concentration to be detected by this method d IgA is the antibody commonly produced in people with hay fever

    c IgE is in too low a concentration to be detected by this method

  • 3

    Which test is used to evaluate the cellular immune system in a patient? a_ skin test for commonly encountered antigens b determination of isohemagglutinin titer ¢ immunoelectrophoresis of serum d measurement of anti-HBsAg after immunization

    a_ skin test for commonly encountered antigens

  • 4

    T cells are incapable of: collaborating with B cells in antibody responses secretion of immunoglobulins secretion of cytokines producing positive skin tests

    secretion of immunoglobulins

  • 5

    T lymphocytes are incapable of functioning as: a cytotoxic cells b helper cells c phagocytic cells d regulatory cells

    c phagocytic cells

  • 6

    Nonspecific killing of tumor cells is carried out by: cytotoxic T cells helper T cells natural killer cells antibody and complement

    natural killer cells

  • 7

    Tumor markers found in the circulation are most frequently measured by: a immunoassays b thin-layer chromatography c high-pressure liquid chromatography d colorimetry

    a immunoassays

  • 8

    A patient with a B-cell deficiency will most likely exhibit: decreased phagocytosis increased bacterial infections decreased complement levels increased complement levels

    increased bacterial infections

  • 9

    patient with a T-cell deficiency wil! most likely exhibit: increased immune complex formation increased parasitic infections decreased IgE-mediated responses decreased complement levels

    increased parasitic infections

  • 10

    Which of the following is an important cellular mediator of immune complex tissue injury? a mast cell b neutrophil c basophil d eosinophil

    b neutrophil

  • 11

    hich of the following mediators is released during T-cell activation? immunoglobulins thymosin serotonin cytokines

    cytokines

  • 12

    The HLA antibodies used in histocompatibility typing have been obtained from which of the following? multiparous women nonidentical siblings sheep blood rabbit serum

    multiparous women

  • 13

    Which of the following terms describes a graft between genetically unidentical individuals belonging to the same species? autograft isograft allograft xenograft

    allograft

  • 14

    Incompatibility by which of the following procedures is an absolute contraindication to allotransplantation? a MLC (mixed lymphocyte culture) b HLA typing c Rh typing d ABO grouping

    d ABO grouping

  • 15

    Which is a recognized theory of the origin of autoimmunity? a enhanced regulatory T-cell function b diminished helper T-cell activity c production of antibodies that cross-react with tissue components d deficient B-cell activation

    c production of antibodies that cross-react with tissue components

  • 16

    C3b and Fc receptors are present on: B lymphocytes monocytes B lymphocytes and monocytes neither B lymphocytes and monocytes

    B lymphocytes and monocytes

  • 17

    T lymphocytes that possess the CD8 surface marker mediate which of the following T-cell functions? delayed type hypersensitivity regulatory cytotoxic helper

    helper

  • 18

    Delayed hypersensitivity may be induced by: contact sensitivity to inorganic chemicals transfusion reaction anaphylactic reaction bacterial septicemia

    contact sensitivity to inorganic chemicals

  • 19

    The most rapid immediate hypersensitivity reaction is associated with: transfusion anaphylaxis contact dermatitis serum sickness

    anaphylaxis

  • 20

    The normal controls for a quantitative B lymphocyte assay should have a value of what percentage of total lymphocytes counted? a 21% b 48% c 76% d 89%

    a 21%

  • 21

    An immunofluorescence test using reagent antibody directed against the CD3 surface marker would identify which of the following cell types in a sample of human peripheral blood? all mature T lymphocytes T helper lymphocytes only cytotoxic T lymphocytes only T regulatory cells only

    all mature T lymphocytes

  • 22

    Refer to the following results for peripheral blood samples: % T lymphocytes patient #1: 85% patient #2: 23% patient #3: 51% patient #4: 82% normal control: 44% The data above indicates: a patient #1 has an abnormally high T lymphocyte count b patient #2 has a normal T lymphocyte count ¢ patients #1 and #3 have normal T lymphocyte counts d_ the normal control is too low and another sample should be selected

    the normal control is too low and another sample should be selected

  • 23

    Refer to the following flow cytometric data. absolute WBC: 8,930 total lymphocytes: 30% B lymphocytes: 40% T lymphocytes: 58% Calculate the absolute count for B lymphocytes. a 1,072 b 2,679 c 3,572 d 6,251

    a 1,072

  • 24

    A concentrate of lymphocytes can be prepared from peripheral blood by: a density gradient centrifugation b ultracentrifugation c zone electrophoresis d_ freeze fractionation

    a density gradient centrifugation

  • 25

    In flow cytometry, labeled cells: scatter the light and absorb fluorescence absorb fluorescence and emit electronic impulses scatter the light and emit fluorescence absorb both fluorescence and light

    scatter the light and emit fluorescence

  • 26

    A marked decrease in the CD4 lymphocytes and decrease in the CD4/CD8 ratio: is diagnostic for bacterial septicemia may be seen in most hereditary immunodeficiency disorders is associated with a viral induced immunodeficiency is only seen in patients with advanced disseminated cancer

    is associated with a viral induced immunodeficiency

  • 27

    Refer to the following data from a peripheral blood sample: total WBC: 10.0 x 109/uL Differential: neutrophils: 68% lymphocytes: 25% (40% T cells) monocytes: A% eosinophils: 2% basophils: 1% The expected total number of T cells is: a 200 b 1,000 c 2,000 d 2,500

    b 1,000

  • 28

    A peripheral blood total leukocyte count is 10.0 x 103/yL. The differential reveals 55% neutrophils, 2% eosinophils, 40% lymphocytes and 3% monocytes. Assuming a lymphocyte recovery of 85%-95%, what is the expected number of T cells in a normal individual? a 750/pL b 2,500/pL © 4,000/pL d 8,000/pL

    b 2,500/pL

  • 29

    In laser flow cytometry, applying a voltage potential to sample droplets as they stream past the light beam and using charged deflector plates results in: an emission of red fluorescence from cells labeled with fluorescein isothiocyanate an emission of green fluorescence from cells labeled with rhodamine a 90° light scatter related to cell size the separation of cells into subpopulations based on their charge

    the separation of cells into subpopulations based on their charge

  • 30

    What is the immunologic method utilized in the flow cytometer? latex agglutination enzyme linked immunoassay immunofluorescence radioimmunoassay

    immunofluorescence

  • 31

    Given the following data: WBC: 5.0 x 10%pL lymphs: 15% CD4: 8% Calculate the absolute CD4: a 40 b 60 c 400 d 750

    b 60

  • 32

    Given this hematologic data: WBC: 5.0 x 103/uL lymphs: 15% cD4: 8% Which of the following is the correct interpretation? a CD4% and absolute CD4 normal b consistent with an intact immune system c consistent with a viral infection such as HIV d technical error

    c consistent with a viral infection such as HIV

  • 33

    Bone marrow transplant donors and their recipients must be matched for which antigen system(s)? ABO-Rh HLA CD4/CD8 P1^a1

    HLA

  • 34

    A 28-year-old man is seen by a physician because of several months of intermittent low back pain. The patient's symptoms are suggestive of ankylosing spondylitis. Which of the following laboratory studies would support this diagnosis? a a decreased synovial fluid CHsp level b low serum CH50 level c positive HLA-B27 antigen test d rheumatoid factor in the synovial fluid

    c positive HLA-B27 antigen test

  • 35

    Cells from a patient with hairy cell leukemia have immunologic and functional features of: a mast cells and B lymphocytes b B lymphocytes and T lymphocytes c granulocytes and monocytes d B lymphocytes and monocytes

    d B lymphocytes and monocytes

  • 36

    Which T-cell malignancy may retain “helper” activity with regard to immunoglobulin synthesis by B cells? Hodgkin lymphoma acute lymphocytic leukemia (ALL) Sézary syndrome chronic lymphocytic leukemia (CLL)

    Sézary syndrome

  • 37

    patient’s abnormal lymphocytes are positive for CD2 antigen, lack C3 receptors, and are negative for surface immunoglobulin. This can be classified as a disorder of: T cells B cells monocytes natural killer cells

    T cells

  • 38

    HLA typing of a family yields the following results: On the basis of these genotypes, predict the possibility of ankylosing spondylitis in this percentage Locus A Locus B father (8, 12) (17, 22) mother (7, 12) (13, 27) of their children. a 25% of their children b 50% of their children c 75% of their children d 100%

    b 50% of their children

  • 39

    HLA-B8 antigen has been associated with which of the following pairs of diseases? an op ankylosing spondylitis and myasthenia gravis celiac disease and ankylosing spondylitis myasthenia gravis and celiac disease Reiter disease and multiple sclerosis

    myasthenia gravis and celiac disease

  • 40

    Which of the following is an important marker for the presence of immature B cells in patients with acute lymphocytic leukemia (ALL)? ans oe terminal deoxynucleotidyl transferase (TdT) adenosine deaminase glucose-6-phosphate dehydrogenase purine nucleoside phosphorylase

    terminal deoxynucleotidyl transferase (TdT)